Skip to content

LTRN

Lantern Pharma Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.55
−9.36%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-55.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 14, 2026KEYSER D JEFFREY · directorPurchase48,544$2.06
May 14, 2026Schalop Lee Troy · directorPurchase48,544$2.06
Jan 13, 2026Maccecchini Maria-Luisa · directorA-Award25,000$3.49
Jan 13, 2026Chandru Vijay · directorA-Award25,000$3.49
Jan 13, 2026KEYSER D JEFFREY · directorA-Award28,844$3.49
Jan 13, 2026Chandru Vijay · directorA-Award17,307$3.49
Jan 13, 2026Schalop Lee Troy · directorA-Award25,000$3.49
Jan 13, 2026Schalop Lee Troy · directorA-Award18,460$3.49
Jan 13, 2026Silberstein David S. · directorA-Award25,000$3.49
Jan 13, 2026Silberstein David S. · directorA-Award17,307$3.49
Jan 13, 2026Maccecchini Maria-Luisa · directorA-Award21,152$3.49
Jan 13, 2026KEYSER D JEFFREY · directorA-Award25,000$3.49
Dec 22, 2025Bhatia Kishor G. · officer: Chief Scientific OfficerA-Award10,000$3.24
Dec 22, 2025Margrave David R. · officer: Chief Financial OfficerA-Award20,000$3.24
Sep 23, 2025KEYSER D JEFFREY · directorA-Award3,200$5.04
Sep 23, 2025Bhatia Kishor G. · officer: Chief Scientific OfficerA-Award17,400$5.04
Sep 23, 2025Margrave David R. · officer: Chief Financial OfficerA-Award26,100$5.04
Sep 23, 2025Silberstein David S. · directorA-Award9,135$5.04
Sep 23, 2025Silberstein David S. · directorA-Award3,200$5.04
Sep 23, 2025KEYSER D JEFFREY · directorA-Award9,135$5.04
Sep 23, 2025SHARMA PANNA · director, officer: President & CEOA-Award76,628$5.04
Sep 23, 2025Margrave David R. · officer: Chief Financial OfficerA-Award78,300$5.04
Sep 23, 2025Bhatia Kishor G. · officer: Chief Scientific OfficerA-Award52,200$5.04
Sep 23, 2025Chandru Vijay · directorA-Award9,135$5.04
Sep 23, 2025Chandru Vijay · directorA-Award3,200$5.04
Aug 20, 2025Schalop Lee Troy · directorA-Award5,000$4.46
Jun 13, 2025Kreis Leslie W. · 10 percent ownerSale338$3.40
Jun 13, 2025Kreis Leslie W. · 10 percent ownerSale21,557$3.38
Jun 13, 2025Kreis Leslie W. · 10 percent ownerSale293$3.40
Jun 13, 2025Kreis Leslie W. · 10 percent ownerSale18,678$3.38
Institutional positioning

13F filings over the trailing two quarters

New 17Increased 18Reduced 19Sold out 6
FilerActionSharesFiled
BIOS CAPITAL MANAGEMENT, LPReduced864,435May 13, 2026
Empery Asset Management, LPNew Position842,669Aug 11, 2026
CM Management, LLCIncreased500,000Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased425,118Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position332,079May 15, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased291,039Aug 13, 2026
CM MANAGEMENT, LLCIncreased250,000May 8, 2026
BIOS Capital Management, LPReduced249,397Aug 14, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased116,000May 14, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased111,646May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced102,819Aug 12, 2026
WESTSIDE INVESTMENT MANAGEMENT, INC.Increased50,050May 4, 2026
VOSS CAPITAL, LLCUnchanged50,000May 15, 2026
VANGUARD FIDUCIARY TRUST COIncreased49,950Aug 13, 2026
VANGUARD FIDUCIARY TRUST CONew Position49,607May 8, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 14, 2026